Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review

J Addict Dis. 2024 Jul-Sep;42(3):253-263. doi: 10.1080/10550887.2023.2195777. Epub 2023 May 18.

Abstract

The opioid epidemic and limited access to treatment for opioid withdrawal (OW) and opioid use disorder (OUD) has led individuals to seek alternative treatments. This narrative review aims to educate clinicians on the mechanisms of action, toxicity, and applications of psychoactive plant-based substances patients may be using to self-treat OUD and OW. We specifically discuss ayahuasca, ibogaine, and kratom as they have the most evidence for applications in OUD and OW from the last decade (2012-2022). Evidence suggests these substances may have efficacy in treating OW and OUD through several therapeutic mechanisms including their unique pharmacodynamic effects, rituals performed around ingestion, and increased neuroplasticity. The current evidence for their therapeutic application in OUD and OW is primarily based on small observational studies or animal studies. High-quality, longitudinal studies are needed to clarify safety and efficacy of these substances in treatment of OW and OUD.

Keywords: Opioid withdrawal; ayahuasca; ibogaine; kratom; opioid use disorder.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Banisteriopsis* / chemistry
  • Humans
  • Ibogaine* / analogs & derivatives
  • Ibogaine* / pharmacology
  • Ibogaine* / therapeutic use
  • Mitragyna* / chemistry
  • Opioid-Related Disorders* / drug therapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Psychotropic Drugs / therapeutic use
  • Substance Withdrawal Syndrome* / drug therapy
  • Tabernaemontana / chemistry

Substances

  • Ibogaine
  • Plant Extracts
  • Psychotropic Drugs